Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flow from operating activities:
Net loss	$ (1,194,117)	$ (196,213)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	12,144	8,828
Amortization of lease right	0	72,331
Fair value of vested stock options	424,450	504,936
Fair value of vested restricted common stock	446,433	281,148
Changes in operating assets and liabilities:
Accounts receivable	(904,915)	(563,829)
Prepaid expenses and other current assets	(67,984)	(75,473)
Prepaid royalties	(54,287)	(23,146)
Deposits and other assets	0	5,360
Accounts payable and accrued expenses	397,088	1,208,474
Deferred revenue	538,477	1,076,966
Lease liability	0	(79,326)
Net cash provided by (used in) operating activities	(402,711)	2,220,056
Cash flow from investing activities:
Purchase of property and equipment	(34,251)	(11,853)
Net cash used in investing activities	(34,251)	(11,853)
Cash flow from financing activities:
Proceeds from the exercise of stock options	97,688	88,850
Proceeds from the exercise of warrants	59,500	81,251
Common stock repurchase	(82,053)	(150,386)
Repurchase of stock options and warrants	0	(308,313)
Net cash provided by (used in) financing activities	75,135	(288,598)
Effect of exchange rate changes	(1,989)	2,401
Net increase (decrease) in cash and cash equivalents	(363,816)	1,922,006
Cash and cash equivalents, beginning of period	11,004,337	9,311,556
Cash and cash equivalents, end of period	10,640,521	11,233,562
Supplemental disclosures of cash flow information:
Cash paid for income taxes	$ 6,592	$ 3,077